RA CAPITAL MANAGEMENT, L.P. reported option exercise involving 40,000 shares of Climb Bio, Inc. at $1.29 for $51.6k on Sep 28, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Sep 30, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$51,600Shares × reported price
Shares traded
40,000Common Stock
Price per share
$1.29Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
70,000Indirect · See footnotes
Trade date
Sep 28, 2026Option exercise
Filed
Sep 30, 2026, 4:55 PM ET2-day reporting delay
Accession
0001231919-26-001416Code M · Transaction 231928
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 28, 2026Option exercise10,000$3.46$34,600Trade 231925
Sep 28, 2026Option exercise10,000$3.00$30,000Trade 231926
Sep 28, 2026Option exercise10,000$7.89$78,900Trade 231927
Sep 28, 2026Option exercise10,000$0.00$0Trade 231929
Sep 28, 2026Option exercise40,000$0.00$0Trade 231932
6 transaction rows in this filing. Joint filers share the same rows.

CLYM price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CLYM · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +27%1w ago +19%1d ago +1.7%
Returns since7d −6.6%30d −9.9%90d180d1y

Footnotes in full

F1: RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund, L.P. (the "Nexus Fund"), RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"), RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund, the Nexus Fund II, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein. F2: This option was granted to Andrew Levin pursuant to the Issuer's non-employee director compensation policy. Under Dr. Levin's arrangement with the Adviser, Dr. Levin held the option for the benefit of the Fund, the Nexus Fund, the Nexus Fund II, the Nexus Fund III, and the Account. Dr. Levin is obligated to turn over to the Adviser any stock received upon exercise of the option, which will offset advisory fees owed by the Fund to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock. F3: These securities are held directly by Fund. F4: These securities are held directly by the Nexus Fund. F5: These securities are held directly by the Nexus Fund II. F6: These securities are held directly by Nexus Fund III. F7: These securities are held directly by the Account. F8: Immediately exercisable.